发明名称 |
Reprogramming Blood Cells to Pluripotent and Multipotent Stem Cells |
摘要 |
The present invention is based on the seminal discovery that cord blood (CB) and adult bone marrow (BM) CD34+ cells can be reprogrammed to early stem cells. The invention provides the reprogramming of CB and adult bone marrow (BM) CD34+ cells from subjects without any pre-treatment. Provided are methods for reprogramming blood cells of a subject. Also provided are methods of disease modeling and methods of generating subject-specific differentiated cells. In addition, the invention provides methods of identifying an agent that alters a function of subject-specific differentiated cells as well as isolated pluripotent or multipotent stem cells reprogrammed from blood cells. |
申请公布号 |
US2015139961(A1) |
申请公布日期 |
2015.05.21 |
申请号 |
US201414295623 |
申请日期 |
2014.06.04 |
申请人 |
The Johns Hopkins University |
发明人 |
Cheng Linzhao |
分类号 |
C12N15/85;C12N5/074;A61K35/28;G01N33/50 |
主分类号 |
C12N15/85 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method for generating a pluripotent or multipotent stem cell comprising:
introducing a non-viral vector containing at least one pluripotency factor into a blood cell in culture, thereby reprogramming the blood cell to a pluripotent or multipotent stem cell. |
地址 |
Baltimore MD US |